Abstract
Breast cancer, the most frequent cancer in females is the major cause of morbidity and mortality in the world as well as in Pakistan. Screening of breast cancer or early detection requires a reliable biomarker that has high specificity and sensitivity for use in clinical practice. Certain diagnostic biomarker have been identified but are not fit for clinical use due to their low sensitivity like MUC1 (mucin glycoprotein) and CA 15-3 and CA 27-29 (cancer antigens)
Naila Irum Hadi. (2015) “Metabolomics” In Breast Cancer Diagnosis, The Pakistan Journal of Medicine and Dentistry, Volume-4, Issue-2.
-
Views
593 -
Downloads
73
Article Details
Volume
Issue
Type
Language
